BioPartnering North America Offers Unique Presenting Opportunities for Innovative Life Science Companies: Financial News

BioPartnering North America Offers Unique Presenting Opportunities for Innovative Life Science Companies
Wednesday November 5, 2008 2:13 pm ET

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Nov 5, 2008 -- Technology Vision Group LLC (TVG) is pleased to announce that it is now accepting applications for company presentations at the 7th Annual BioPartnering North America conference (BPN), which will be held at the Westin Bayshore Resort in Vancouver, B.C., Canada, on February 8-10, 2009, and co-hosted by LifeSciences British Columbia, BIOTECanada, and BioAlberta.

Presenting opportunities will be limited to 114 companies and with less than 40 company presentation slots still available, places are filling up quickly. Applications to present can be submitted online at: http://www.techvision.com/bpn/apply/.

BioPartnering North America provides unparalleled opportunities for innovative biotech companies from across the world to showcase their technologies and products, as well as forming valuable and meaningful business relationships. Last year's conference featured 100 company presentations, with over 900 attendees from nearly 500 international life science companies and organizations. BPN offers two presentation formats focused on business development and forming partnerships. To see a list of companies that attended BPN 2008, visit http://www.techvision.com/bpn/participants/.

Company Presentations

This year, BPN will showcase ninety-four innovative companies from all parts of the world in 13-minute podium presentations in the Cowichan and Coquitlam rooms. Company presentations provide excellent exposure for companies to a broad spectrum of international life science business development executives from the biotech, pharmaceutical, investor, government and academic communities. In the past BPN podium presentations have featured many young companies that have gone on to become some of the industry's most important players.

Open House Presentations

A hallmark of BPN, the Open House format will feature 20 companies offering interactive presentations in specially constructed booths in Salon D, which is located directly across from the registration desk on the main floor. This year's Open House features leading biotech companies and representatives from biotech clusters around the world. Open House presenters will be available during a two-hour period for interactive presentations and informal discussions with business development executives to promote their innovative technologies and partnering goals. Open House presenters will also have the opportunity to use their semi-private booths for five hours to schedule one-on-one partnering meetings with interested attendees.

The Power of biopartnering.com

BPN attendees will have access to biopartnering.com, the leading life science conference partnering tool. biopartnering.com lets attendees pre-schedule meetings in advance of the event, prospect attendees, and use effective time-management tools to create the optimal conference experience and make the best use of time onsite. Presenting companies may also submit a short video to biopartnering.com that can be viewed in a dedicated area by all attendees, letting presenting companies promote themselves in advance of the event in a dynamic and engaging manner. BPN 2008 attendees enjoyed a 40% increase in the number of meetings scheduled.

Full Program of Sessions, Workshops, and Networking Opportunities

A full program of BioPartnering Leadership Sessions, Sponsor Workshops, and outstanding networking opportunities with senior executives from the life sciences takes place at BPN, creating an environment of business development activities that is focused on partnering.

Canadian Bursary

Technology Vision Group LLC is strongly committed to the Canadian biotechnology industry, and together with BIOTECanada, has financed scholarships to allow students from across Canada to attend BioPartnering North America (BPN). For details on deadlines and how to apply, please contact Graeme Fraser, BIOTECanada at +1.613.230.5585 x233.

Full details about BioPartnering North America online at: http://www.techvision.com/bpn.

Hosts

BioAlberta, BIOTECanada, LifeSciences British Columbia

Platinum Sponsors

AstraZeneca

Gold Sponsors

Burrill & Company; Farris, Vaughn, Willis & Murphy Barristers and Solicitors; Pfizer

Silver Sponsors

Bristol-Myers Squibb; Merck & Co., Inc.; Procter & Gamble Pharmaceuticals; Anapharm; Roche, Crucell

Conference Sponsors

Genome British Columbia

Conference Supporters

Citigate Dewe Rogerson, Contact Canada®, MarketWire, and Washington Biotechnology & Biomedical Association (WBBA)

Media Supporters

FierceBiotech, BioBusiness, Biotechnology Focus, Nature Publishing Group, European Biopharmaceutical Review, Progress Research and Discovery Magazine.

2009 Open House Presenters

Apthera, Inc.; Bend Research; Ceapro Inc.; Ambassade de France Mission economique; Ambit Biosciences; UK Trade & Investment; CIRION Clinical Trial Services Inc.; ImmunoVaccine Technologies Inc.; Inimex Pharmaceuticals, Inc.; Pharmatek Laboratories, Inc.; Piramal Healthcare; Prince Edward Island Business Development; Protalix Biotherapeutics Ltd.; QSV Biologics Ltd.; Silence Therapeutics AG.

2009 Podium Presenters

Apthera, Inc.; Bend Research; Ceapro Inc.; Agile Therapeutics, Inc.; AIM Therapeutics Inc.; Akesis Pharmaceuticals, Inc.; Alpharma Pharmaceuticals LLC; Apeiron Biologics; Aquinox Pharmaceuticals Inc.; Biolex Therapeutics; Bionor Immuno AS; Bionovo, Inc.; BioWisdom Ltd.; Calibrant Biosystems, Inc.; Cellzome AG; CoMentis, Inc.; Critical Pharmaceuticals Ltd.; Curis, Inc; iCo Therapeutics Inc.; Innate Pharma; InNexus Biotechnology Inc.; Inovio Biomedical Corp.; Jerini AG; KAI Pharmaceuticals Inc.; Medatrina Pharmaceuticals, Inc.; Metanomics Health GmbH; Micromet AG; Modigene Inc.; Nektar Therapeutics; Nerites Corporation; Novacta Biosystems Limited; Numerate, Inc.; Oncogenex Pharmaceuticals, Inc.; Oncolytics Biotech Inc.; Protein Forest, Inc.; Proteos, Inc.; PRUDENTAS LLC; Sandoz International GmbH; SemBioSys Genetics; Signum Biosciences Inc.; Stem Cell Therapeutics; Stromedix, Inc.; SuppreMol GmbH; Transcept Pharmaceuticals; Vakzine Projekt Management GmbH; VLST Corp.; Xenome Limited; YM BioSciences Inc.; Zymeworks.